print-logo
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our purpose & values
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial
    • Patient Advocacy
    • Lifecycle Management
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-Through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • Open positions
    • Career paths
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to Publications
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

Changing Role of Medical Affairs

Video interview with Tanja Bosshard Becker and Clifford Hall

Medical Affairs needs to step up, provide true value by addressing real unmet needs and start taking strategic decisions. It needs to go beyond medical competence & solid research.

Medical should become the driving force in a company to deliver value, communicate it in evidence-based actions and build trust. 

Interview: Changing Role of Medical Affairs

Why does Medical Affairs need to change?

(Clifford) That is an interesting question. The industry is responding to an increased focus on value and outcomes across all stakeholders. At the same time, there are new and changing rules governing interactions and collaboration with these stakeholders. These changes demand interactions that are evidence-based and that build trust. 

Knowledgeable, competent Medical Affairs teams are needed to lead these interactions. 

(Tanja) The need for Medical Affairs to step up has actually been around for a while. Focusing on short-term financial gain during the time of blockbusters has erroded trust in the industry. But in practice it is still occurring more frequently than it should, so it's no wonder that scrutiny and regulation is ever increasing. 

It's not a choice anymore: industry needs to focus on providing true value by addressing real unmet medical needs, and of course delivering solid evidence for that value provided. And it's Medical Affairs who's best equipped to lead this shift. 

Why are many companies struggling with this change?

(Tanja) Often, commercial teams still own strategy and decisions. Yet, their role needs to change to that of a coordinator. At the same time, Medical has to step up. As trusted experts, they should become an equal partner in strategy development and decision-making, driving patient and medical focus. 

They need to strengthen evidence-generation and sharing. This means change to culture, processes and organization, and often there is a need to build respect for Medical Affairs capabilities. 

It's a fundamental change, which is never quick or easy. A McKinsey survey has found that around 70% of change efforts do not achieve target. 

(Clifford) Change is not always easy, and the change to a new Medical Affairs model is no exception. 

If for example, you look at the competencies, career paths and incentives in the past, versus what is needed today, the gaps come into focus. Today, Medical Affairs professionals must not only be medically competent and able researchers who act as guardians of medical accuracy and product safety, but must now also be even more engaging as outward-focused educators, collaborators and facilitators of scientific exchange. 

What is needed to make the shift?

(Clifford) A transformation is needed that takes Medical Affairs beyond traditional research and internal administration to a position where Medical Affairs takes on the role of therapeutic area leadership in a company. Different companies are at different stages on that journey. 

It is not something that will happen spontaneously, or overnight, and needs to be carefully assessed, planned and executed. 

(Tanja) Transformation that fundamental is only possible with buy-in from all internal parties: Management and employees. It needs a holistic approach, but it remains a must.

Medical should become the driving force behind a pharma company's efforts to deliver value, to communicate it in evidence-based interactions, and - hopefully - build trust. 

Contact our experts

Tanja Bosshard Becker

Tanja Bosshard Becker

Partner

mail_icon linkedin_icon
Clifford Hall

Clifford Hall

Subject Matter Expert

mail_icon

Related Publications

Publication Preview Image

May 09 2016

Medical Affairs- The time for change is now

Publication Preview Image

May 12 2021

Product launches: making the most of your one shot

Publication Preview Image

June 29 2020

Patient centricity standards, criteria and KPIs across the biopharma industry (Part 1)

Publication Preview Image

September 09 2020

Patient centricity standards, criteria and KPIs across the biopharma industry (Part 2)

Publication Preview Image

August 03 2020

Value-based healthcare in practice: how far have we come?

Publication Preview Image

January 25 2021

How pharma can navigate ups and downs of vertical integration in US

Share this page
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2023 Executive Insight. All rights reserved.